In our study, SKP2 was validated as the downstream target of YAP involved in cell cycle progression in cancer, which was consistent with previous research that YAP directly regulates SKP2 transcription (Stein et al., 2015; Jang et al., 2017). Here, SKP2 is linked to cancer.